News & media

Virbac: Manuela Rodriguez appointed CSR (Corporate social responsibility) director

2023/05/31 - Career

Rodriguez-Manuela.gifVirbac announces the appointment of Manuela Rodriguez as CSR director, effective April 3, 2023. Her main mission will be to develop and manage the Group's CSR strategy. 

Read more

Virbac Spain: 40 years of commitment

2023/05/15 - Press

Vignette_Corpo_40ans-VB_ES.jpgFounded in 1983, Virbac Spain, one of the Group's oldest subsidiaries, celebrated 40 years of commitment to animal health on 11 May.

Read more

DailyDerma: a new routine for long-lasting relief for atopic dogs

2023/05/12 - Products

Vignette_Corpo_DailyDerma.pngAtopic dermatitis is an inflammatory skin disease that affects 10% of dogs1. Very disabling for the animal, it is also complex to diagnose and treat. To improve its management, our teams have developed DailyDerma: an innovative programme that brings together veterinarians and owners for better long-term management of the disease.

Read more

Central Europe: Virbac acquires its distributor in the Czech Republic and Slovakia

2023/05/02 - Press

Corpo_VB_CZ.jpgOn May 2, we finalized the acquisition of 100% of the shares of our historical distributor in the Czech Republic and Slovakia, which becomes the 35th Virbac subsidiary. Welcome!

Read more

Dog and cat nutrition and health: Veterinary HPM® now in India!

2023/04/24 - Products

Corpo_HPM_Inde.jpgIn 2015, our Veterinary HPM® dog and cat foods made their first appearance in Europe; they are now present in more than 30 countries worldwide. In 2023, we are continuing their development in Asia: after Japan, they have been available in India since last March, providing veterinarians and owners in the country with a preventive nutrition solution that contributes to the health of domestic carnivores.

Read more

Ireland: creation of a new Virbac subsidiary

2023/04/21 - Press

Ireland.jpgOn January 1, 2023, we finalized the creation of Virbac Ireland, our 34th subsidiary!

Read more

2023 first quarter consolidated sales

2023/04/17 - Financial public releases

Slight decline in first-quarter revenue primarily due to a base effect as well as a context of market slowdown

Read more

Heartworm prevention: new solution in Central & Eastern Europe

2023/04/07 - Products

Vignette_corpo_Afilaria.jpgHeartworm disease is a potentially fatal pathology affecting mostly dogs. Endemic to the Mediterranean basin, it appeared in Eastern Europe about ten years ago. Since February 2023, our teams have been offering veterinarians and owners in this region of the world a new, easy-to-use annual preventive solution to protect their pets effectively1

Read more

Giovanni Abruzzini named president and CEO of Virbac North America

2023/03/27 - Career

Abruzzini_Giovanni.jpgVirbac announces Giovanni Abruzzini’s appointment as president and CEO of Virbac North America, effective March 27, 2023. His main mission is to lead and develop all North American Virbac activities, in line with our Group’s global strategy. 

Read more

2022 annual results

2023/03/23 - Financial public releases

2022 current operating income on the rise at +8.3%, reflecting the momentum of our business over the year in a slowing market

Read more

Dairy production: our teams innovate to better target the treatment of mastitis at dry-off

2023/03/21 - Products

Corpo_Smart_DCT.jpegOn February 21, our farm animals team organized a webinar attended by nearly 900 veterinarians from all over the world. The objective? To present our new Smart DCT tool, which allows a better assessment of the infectious pressure in dairy herds during the dry period. This action aims at supporting better adapted treatments and a more responsible use of antibiotics.

Read more

Virbac advances rotavirus prevention in swine farming

2023/02/02 - Products

Vignette_corpo_suigen_rota_coli.jpgRotavirus is one of the main agents causing diarrhea in piglets1. Since December 2022, our teams have been providing industry professionals in France and Germany with the very first rotavirus vaccine registered for pigs, enabling the immunization of newborn piglets via their mother’s colostrum.

Read more

2022 fourth quarter consolidated sales

2023/01/18 - Financial public releases

Annual revenue growth of +9.6% at comparable exchange rates and scope (+14.3% at real rates), driven by exceptional business activity in the fourth quarter

Read more

Happy new year 2023!

2023/01/02 - Press

Discover the video on the 2023 wishes of Sébastien Huron to all the teams in the world.

Read more

Virbac Colombia: 20 years already!

2022/12/22 - Press

Vignette_Corpo_20years_Colombie.jpgIn February 2022, Virbac Colombia celebrated its 20 years of commitment to animal health with all its employees and then, on November 4th, with the partners of its Colombian subsidiary and the Andean region, Sandrine Brunel as representative of the head office, the LatAm committee and the entire management team of Virbac Colombia & Andes.

Read more

Taiwan: opening ceremony of a new R&D center

2022/12/19 - Press

Opening-TW-vignette.jpgOn November 30, Virbac inaugurated its new R&D center in Pingtung Agricultural Biotechnology Park (PABP) in Taiwan which marked an important milestone for Virbac R&D.

Read more

2023 Outlook

2022/12/19 - Financial public releases

Read more

Great Place To Work® workshops: local practices in the spotlight!

2022/12/15 - Career

Handicap Vignette 300x200.jpgBetween May and June 2022, some thirty employees from each of our subsidiaries met for international Great Place To Work® workshops to discuss the local employee experience and best practices within certified companies. 

Read more

A new joint supplement to help dogs remain naturally active

2022/12/15 - Products

vignette_site_corporate_Mobility.jpgMobility issues are common in dogs and can greatly impact their quality of life. To keep their joints healthy, our teams have developed MOVOFLEX®, a new joint supplement combining five ingredients, including eggshell membrane. It includes an innovative formulation, gradually available in Europe from November 2022, for a complete action that significantly contributes to improving the animal's mobility.

Read more

Companion animal vaccines: investment in Carros

2022/11/29 - Press

Vignette_Savannah.jpgTo meet the global needs for pet vaccines, including those of certain countries such as China, a new aseptic filling line dedicated to liquid vaccines and diluents has been installed at VB8, a building dedicated to the manufacture of sterile forms.

Read more

Latin america: neutering of male dogs evolves

2022/11/28 - Products

visu_LATAM_vignette_corpo.jpgPet reproduction control habits vary from one country to another. In Latin America, 60 to 70% of male dogs are not castrated, often because dog owners are concerned about the surgery and its possible consequences. Alternative solutions exist and are available in a growing number of countries in this area. Danilo Martinez, our Latin America pet marketing manager at Virbac, tells us more.

Read more

New collaboration with the WSAVA!

2022/10/20 - Press

Corpo_visuel_Wsava.jpgSince this month of October, we are an official sponsor of the World Small Animal Veterinary’s Reproduction Control Committee. Our common goal? To promote, on a worldwide level, the best veterinary practices in this key field for the health of cats and dogs. 

Read more

2022 third quarter consolidated sales

2022/10/18 - Financial public releases

Revenue growth at end of September at +7.7% at comparable exchange rates and perimeter (+12.7% at actual rates)

Read more

Virbac to set up a new site in Nîmes to house its petfood production

2022/10/12 - Press

Marvel.gifTo meet the growing demand for our petfood range, we will build a new production site in Nîmes (Gard, France). This evolving site will integrate all the steps from raw materials to the finished product.

Read more

Sophie Favini appointed head of Global Business Operations for Virbac

2022/09/30 - Career

Sophie-Favini-1.jpgVirbac announces the appointment of Sophie Favini as the Group's new head of Global Commercial Operations. Previously the executive vice-president of Virbac's USA Commercial Operations, Sophie Favini, based in Westlake, Texas, replaces Hubert Trentesaux who has retired.

Read more

2022 half year results

2022/09/15 - Financial public releases

Increase in operating income in the first half of 2022 reflecting the dynamism of our business

Read more

WBC Congress: Virbac's scientific expertise in the service of bovine health

2022/09/08 - Press

Vignette_site_corporate_WBC.jpgIn September 2022, our teams have answered to advance preventive medicine at the largest world congress of buiatrics.

Read more

2022 second quarter consolidated sales

2022/07/19 - Financial public releases

Growth in revenue in the first half of 2022 of +12.0% at comparable exchange rates (+16.4% at real rates), driven by good performance in all areas

Read more

Livestock health: Virbac launches TENOTRYLTM (enrofloxacin) injectable solution in the USA and increases its range of products

2022/07/11 - Products

visu_corpo_vignette_tenotryl.jpgWe continue to increase our footprint in the livestock market and are proud to announce the launch of TENOTRYLTM (enrofloxacin) injectable solution for use in cattle and swine. Our product was approved by the FDA on March 28th and will be available to those who care for animals beginning in July. TENOTRYLTM (enrofloxacin) injectable solution comes in 100, 250 and 500 ml vials.

Read more

Virbac expands neutering methods for male cats

2022/06/30 - Products

visu_corpo_vignette_EVSSAR.jpgAlthough neutering of pets is sometimes essential, methods are evolving to meet new societal expectations. At Virbac, we offer the Suprelorin® implant, a reversible medical neutering solution. Used since 2007 for male dogs, Suprelorin® obtained on June 14, 2022, an extension of its marketing authorization in the European Union for use in male cats and prepubescent bitches. The extension of its application offers veterinarians new solutions to better adapt to the expectations of owners and the needs of their animals.

Read more

Working with vets to raise awareness of pets’ dental health

2022/06/28 - Products

visu_vignette_corpo_FECAVA.jpgOral health is essential to the overall health and quality of life of cats and dogs, and their owners have an active role to play in preventing dental disease. That is why we recently supported FECAVA's initiative: educational fact sheets to help veterinarians educate owners about the importance of their pets' oral health.

Read more

Cattle health: 30 years of expertise in micronutrition

2022/06/16 - Products

visu_vignette_corpo_cattle.jpgLimiting the use of treatments, in particular antibiotics, by supporting the body's natural processes: this is one of the objectives of micronutrition or trace mineral supplementation. On the occasion of our 30 years of expertise in this field, let's take a look at what has become one of the pillars of our approach to cattle health.

Read more

Launch of Workday Learning

2022/06/15 - Career

vignette_ONE.jpgIn June 2022, Virbac decided to deploy the Learning part in Workday at group level, an agile solution that also meets local requirements. 

Read more

Swine vaccines: heading for latin america

2022/06/14 - Products

Swine_vaccination_Vignette_Corpo.jpgIn June, join us at the IPVS World Congress in Brazil. We are sharing with swine professionals the latest scientific data on porcine circovirus as well as our preventive approach to swine health, which emphasizes vaccination tools and updated technology. 

Read more

Bacteriological active ingredients: a production unit transferred to Carros

2022/06/14 - Press

Vignette_lepto.jpgOur leptospirosis vaccine production capacity will be quadrupled in 2023 thanks to the technological transfer to a high-tech unit!

Read more

Odyssey program: towards the industry of tomorrow

2022/06/13 - Press

Vignette_site_corporate_Odyssey.jpgDeployment of the industrial operations transformation program on June 6, 2022 in North America.

Read more

China: personalized solutions to protect cats and dogs from parasites

2022/06/01 - Products

Milpro_Effipro_Corpo.jpgOn the occasion of the Chinese launch of our key anti-parasite products, Milpro® and Effipro Duo®, Virbac offers an innovative approach based on personalized protocol.

Read more

2022 first quarter consolidated sales

2022/04/14 - Financial public releases

Very strong growth in revenue in the first quarter of 2022 of +16.2% at comparable exchange rates (+19.3% at real rates), driven by good performance in all areas

Read more

Providing sustainable solutions to the global aquaculture boom

2022/03/24 - Products

Aqua_Egypte_vignette_corpo.jpgWith a world population that could reach 9 billion people by 2030, we at Virbac anticipate the growing importance of aquaculture as an essential source of protein for humans in the years to come. We have been present for several years in all key segments of the sector, in warm and cold waters, and in 2022 we will continue our actions to help farmers to meet this growing demand in a sustainable way. Our global approach combines solutions focusing on prevention and services to implement them effectively.

Read more

2021 Annual results

2022/03/22 - Financial public releases

2021 operating profit from ordinary activities showed very strong growth, reflecting the excellent dynamism of our business in a rapidly growing market

Read more

Cat nutrition: Veterinary HPM® now also in chunks in gravy!

2022/03/17 - Products

Wet_Vignette_Corpo.jpgIn order to promote the urinary health of cats, our teams have developed two new wet foods. They will soon be available to cat owners throughout Europe, as an addition to our Veterinary HPM® dry food range.

Read more

Providing our support to the Ukrainian people

2022/03/14 - Press

Since the beginning of the war in Ukraine, our teams have implemented various initiatives to help those facing these tragic circumstances.

Read more

Growth companies summit: Virbac awarded a gold trophy!

2022/02/24 - Press

SEC_Corpo_Vignette.jpgThis new award honors our sustainable development approach.

Read more

Cat & Dog Nutrition: Veterinary HPM enters the US market

2022/02/07 - Products

visuel_vignette_corpo_HPM_US.jpgUnited States: Virbac enters the pet nutrition market with the launch of a product range for neutered and spayed dogs and cats.

Read more

Gaïa Index 2021 : Virbac on the rise!

2022/02/03 - Press

Gaia-index-vignette-site-corpo.jpgDetails of the results of the new CSR ranking.

Read more

2021 fourth quarter consolidated sales

2022/01/19 - Financial public releases

Exceptional growth in annual revenue of +18.4% at comparable exchange rates and scope (+14.9% at constant rates and real scope), driven by remarkable performance in a very buoyant market

Read more

Animal health: to meet the growing needs of vaccine prevention, Virbac transforms its Carros site

2022/01/11 - Press

visu_vignette_corpo_bio5.jpgConstruction of a global center of excellence for biological products has begun in Carros.

Read more

Happy new year 2022!

2022/01/04 - Press

Discover the video on the 2022 wishes of Sébastien Huron, chief executive officer.

Read more

Eco-conception: reduce packaging and wrapping

2021/12/13 - Press

Eco-claims_vignetteCorpo.jpgWe are implementing an eco-responsible approach to supplies and flows.

Read more

2021: take a video tour of the year!

2021/12/09 - Press

Advancing animal health. This is what mobilized our teams on a daily basis throughout 2021. Discover the panorama of the year in a 1 minute video!

Read more

United States: Virbac announces the FDA approval of a tulathromycin injectable and a collaboration with Pharmgate

2021/12/08 - Financial public releases

Vignette_300X200_Porc_0000_P1033761.00_00_10_27.Still001.jpgVirbac's first steps into the U.S. food producing animal market.

Read more

Safety at work: everyone concerned!

2021/11/23 - Press

Video retrospective of the first Virbac days dedicated to safety in France.

Read more

Aquaculture : Virbac completes the acquisition of Centrovet

2021/11/05 - Financial public releases

vignette-corpo-centrovet.pngVirbac announces the acquisition of the remaining minority shares of the Centrovet group.

Read more

Reinventing the approach to neutering of male dogs

2021/10/29 - Products

SuprelorinRA_vignette-corpo.jpgAlthough neutering of pets is sometimes essential, methods are evolving to meet new societal expectations. At Virbac, we have been offering a reversible alternative to surgical castration for several years. In 2021, we are continuing our efforts to make this alternative available to more and more dog owners throughout the world and to support professionals in adopting this solution that is more respectful of the animal's physical integrity.

Read more

2021 third quarter consolidated sales

2021/10/18 - Financial public releases

Excellent revenue growth of 21.2% at the end of September at comparable exchange rates and scope (+16.4% at constant rates and real scope), driven by a very solid third-quarter performance again in all areas

Read more

Great Place to Work: strong progress in results

2021/10/14 - Career

GPTW_300x200.jpgA nice evolution of our new worldwide internal opinion survey.

Read more

Virbac and Jectas Innovators sign an agreement

2021/09/29 - Financial public releases

partenariat-jectas-vignette-corpo.pngVirbac and Jectas Innovators are proud to announce the signature of a collaborative agreement for the development of animal health vaccine(s).

Read more

2021 half year results

2021/09/15 - Financial public releases

Significant increase in operating profit from ordinary activities for the first half of 2021 due to the sound market performance and dynamism of our business

Read more

Aquaculture : Virbac strengthens its position in Centrovet

2021/09/13 - Financial public releases

vignette-corpo-centrovet.pngVirbac announces the acquisition of additional shares in the Centrovet group.

Read more

Nutrition: eco-responsible packaging

2021/08/30 - Press

visuel_vignette_corpo_petfood.jpgInstallation of two new packaging lines for our petfood.

Read more

Virbac is a winner of the "France recovery industry” plan

2021/07/29 - Press

vignette-site-corpo-VP.pngJuly 26, visit to Carros of the prefect for the nice region and the Public accounts deputy minister.

Read more

2021 second quarter consolidated sales

2021/07/20 - Financial public releases

Exceptional increase in revenue in the first half of 2021, with +21.3% at comparable exchange rates and scope (+14% at constant exchange rates and actual scope), driven by very solid performance in all areas and good market dynamics

Read more

Sustainable development: strengthened commitments!

2021/07/15 - Press

VIGNETTE-développement durable (1).jpgNew CSR indicators and GRI compliance for 10 years 

Read more

Virbac Corporation in the USA has completed the acquisition of iVet LLC a specialty petfood company

2021/07/08 - Financial public releases

TEVI-Vignette300x200.jpgAs part of its 2030 vision, Virbac completed the acquisition of iVet LLC, a specialty petfood company. This acquisition, in addition to the portfolio of products, will bring us expertise in distribution, logistics and e-commerce which are part of the key to the success of our petfood ambition in the USA.

Read more

Driven by very solid performance in all areas and a very dynamic market, we are raising our outlook for 2021

2021/07/05 - Financial public releases

2021 Outlook

Read more

Virbac completes divestment of the industrial site located in Magny-en-Vexin (Paris) to Friulchem

2021/07/02 - Financial public releases

Magny_2021.jpgVirbac, today announced the successful completion of its divestment of the production plant located in Magny-en-Vexin to FC France SAS, a subsidiary of Friulchem SpA and Finest SpA. 

Read more

Virbac: Rodolphe Durand appointed as non-voting advisor on the board of directors

2021/06/21 - Financial public releases

Durand_Rodolphe-150x200.jpgAs a non-voting advisor, his role will be mainly to support the good governance of our company by strengthening the complementarity of the skills of the board of directors.

Read more making in-clinic diagnostic monitoring even easier

2021/06/15 - Products

Speed-connect-vignette.jpgSince 2017, we have been offering European veterinarians Speed ReaderTM, an in-clinic analyzer for the determination of blood markers and a series of biomarker tests. This year, we are enriching our in-clinic diagnostic solutions with a software that allows all analyses to be collected on a single digital platform, for optimal monitoring of each animal.

Read more

Whistleblowing system: provision of a new Group platform

2021/06/01 - Career

format_vignette_corpoRA.jpgThe "" tool made available to all teams worldwide.

Read more

Virbac ready to sell the industrial site of Magny-en-Vexin (Paris) to the company Friulchem

2021/05/25 - Press

Magny_2021.jpgAs part of its 2030 vision, Virbac sells the ownership and activity of the Magny-en-Vexin industrial site to Friulchem, a CMO (Contract manufacturing organization) partner of Virbac for more than twenty years and specialized among others in the production of antibiotics. Following the sharp decline in demand in recent years for the type of products manufactured in Magny-en-Vexin, this option will preserve employment, the competitiveness of the site and products.

Read more

Osteoarthritis in dogs: a new breakthrough in the treatment of pain

2021/05/12 - Press

Vignette-site-corpo-Daxocox.jpgAgreement signed for the distribution in Europe of a new weekly anti-inflammatory drug.

Read more

A new breath for the treatment of respiratory diseases in livestock

2021/04/22 - Products

Vignette-site-corpo-SV.jpgRespiratory diseases are one of the most common pathologies affecting cattle and swine: all over the world, they are responsible for a high mortality rate in herds and significant economic losses. At Virbac, we support a reasonable use of antibiotics by using new technologies to help veterinarians and farmers make the right treatment decision at the right time and improve dosage and traceability.

Read more

2021 first quarter consolidated sales

2021/04/15 - Financial public releases

Very strong growth in revenue in the first quarter of 2021 at +22.6% at comparable exchange rates and scope (+12.3% at constant rates), driven by very solid performance in all areas

Read more

2020 annual results

2021/03/17 - Financial public releases

2020 current operating income showed strong growth (+37.6% at constant rates and scope), reflecting the excellent evolution of revenue (+5.7% at constant rates and scope) and a sharp decrease in expenses in the context of the Covid-19 crisis

Read more

Companion animals: Virbac takes over assets from Elanco

2021/03/01 - Press

Information following the approval of the European competition authoritiesvirbac-08-03-2018_300X200.jpg

Read more

Algenex and Virbac sign international commercial licensing agreement for CrisBio®-based vaccine in major swine indication

2021/02/24 - Press

Vignette-Site-corpo-CP-Algenex.jpgFind out the press release issued on February 23rd.

Read more

Virbac opens its first research and development center dedicated to warm water aquaculture

2021/02/23 - Press

VATC_vignette_site-corpo.jpgToday, we are inaugurating our first research and development center dedicated to warm water aquaculture in the Dong Nai province in Vietnam. Aquaculture is a rapidly growing sector, particularly in Asia, and provides an answer to the problems of feeding a world population that could reach 9 billion people in 2030. True to our mission to work for animal health, we continue to invest in order to offer new solutions for more sustainable aquaculture.

Read more

Gaia Index: Virbac progresses in the ranking!

2021/02/12 - Press

Gaia-index-vignette-site-corpo.jpgWe are improving our presence in the ranking of the 70 French companies with the best ratings in terms of social and environmental responsibility.

Read more

2020 fourth quarter consolidated sales

2021/01/19 - Financial public releases

2020 annual revenue shows strong growth of +5.7% at constant exchange rates and scope (+3.2% at constant rates) 

Read more

Virbac and Symbiocelltech sign exclusive option agreement to develop novel technology for treatment of type 1 diabetes in companion animals.

2021/01/13 - Press

CP_Diabte_Vignette-Site-corpo.jpgDiscover the press release issued on january 12th

Read more

Our new solution for the treatment of canine mast cell tumors available soon for american veterinarians

2020/12/21 - Products

CP_US_vignette_site_corporate.jpgOn November 16, 2020 the Food and Drug Administration (FDA) granted approval of our new treatment against canine skin tumors. With this approval, we bring U.S. veterinarians a true innovation in canine oncology and a new option to manage mast cells tumors, the most common skin cancer diagnosed in dogs.

Read more

Happy season’s greetings!

2020/12/18 - Press

Discover the video of Sébastien Huron, chief executive officer of the Virbac group, for the end of the year 2020.

Read more

2020: discover 2020 overview!

2020/12/11 - Press

Ensuring the safety of our employees and maintaining our business essential to the animals' health. These are the two major challenges met in 2020 facing an unprecedented health crisis. We would like to share with you the panorama of this exceptional year on video.

Read more

Animal Needs Are Evolving, And So Are Our Health Solutions!

2020/11/26 - Products

STELFONTA.jpgThe longer life span of pets goes hand in hand with the increase in geriatric diseases, particularly the number of cancers being diagnosed. Since the beginning of 2020, we have been offering European veterinarians an innovative treatment solution that specifically targets mastocytomas, the most common form of canine skin cancer.

Read more

2020 third quarter consolidated sales

2020/10/14 - Financial public releases

Revenue grew +6.8% at constant exchange rates and scope at the end of September 2020 (+5.6% at constant rates) thanks to solid third quarter performance

Read more

Virbac governance evolution

2020/10/13 - Financial public releases

Virbac will change its governance at its shareholders' meeting on December 15

Read more

Virbac partners with Ictyogroup to bring new aquaculture solutions

2020/09/17 - Press

Ictyogroup_site_corporate_300x200.jpgFull details of this new partnership can be found in the joint press release issued on September 15.  

Read more

2020 half year results

2020/09/16 - Financial public releases

Operating profit from ordinary activities up sharply for the first half of 2020 reflecting revenue resiliency and strong expenditure restraint during the Covid-19 crisis

Read more

2020 second quarter consolidated sales

2020/07/20 - Financial public releases

Revenue grew by +5.0% at constant exchange rates in the first half of 2020 (+4.5% excluding Sentinel), impacted by a decline in the second quarter of the year

Read more

We can all enhance our pet’s dental hygiene

2020/07/15 - Products

By 2 years of age, 70% of cats and 80% of dogs have some form of dental disease (Niemiec BA., 2008). Dental care prevention is key to avoid serious and painful disorders that can affect pets’ overall health and lifespan. Let's discover together in this video how we can improve our four-legged companions’ dental hygiene!

Read more

Divestment of US rights

2020/07/02 - Financial public releases

Virbac completes divestment of U.S. Rights to SENTINEL® brands to MSD Animal Health

Read more

Foster a responsible use of parasiticides

2020/06/24 - Products

7.7 billion people on Earth, half live with pets. Every day, dogs and cats are exposed to unwanted parasites, vectors of various diseases that can affect their health and sometimes our own. We are all part of the same ecosystem. Protection against parasites is therefore a necessity that imposes to find the right balance between the health of animals, humans and their environment. That’s why our solutions allow veterinarians and owners to adapt protection to the specific parasite risk of each animal so that, all together, we can contribute to a responsible use of parasiticides.

Read more

Manage your dog's behaviour & fertility

2020/06/12 - Products

In a growing number of countries, companion animals are considered to be sentient beings that are a part of the family. Although sterilization is sometimes necessary, the methods to manage dogs’ fertility and unwanted behaviours are changing to take societal expectations into consideration.

Read more

Virbac Oncology Summit: veterinarians mobilize around the treatment of canine skin tumors

2020/05/13 - Press

VOS-vignette-300x200.jpgOn April 24, more than 350 veterinarians and experts attended our first scientific summit dedicated to veterinary oncology. Thanks to this exclusive online event, European and North American practitioners have been able to discover the latest scientific data and a new treatment option of canine mast cell tumors.

Read more

Signing of an agreement

2020/05/13 - Financial public releases

Virbac to divest U.S. Rights to SENTINEL® brands to MSD Animal Health

Read more

Carros: one of our worldwide production site of dog and cat vaccines will be stopped for at least 6 weeks

2020/05/04 - Press

BIO.jpgSince April 11, 2020, following an underground pipeline rupture, our Bio4 dog and cat vaccine production site has been shut down. We expect to resume operations in June, after a refurbishment allowing the resumption of manufacturing under GMP (Good manufacturing practice) rules.

Read more

2020 first quarter consolidated sales

2020/04/15 - Financial public releases

2020 first quarter revenue rose by +14.3% at comparable exchange rates, significantly impacted by anticipatory buying

Read more

Covid-19: Virbac teams mobilized

2020/03/27 - Press

Covid19-vignette.jpgSince the beginning of the coronavirus outbreak, numerous measures have been taken around the world to protect the health and safety of our employees and ensure the continuity of our commitment to animal health.

Read more

Imago: a promising first assessment

2020/03/19 - Press

Today, more than ever, we are striving to make our animal health solutions even more accessible to veterinarians, farmers and animal owners around the world. This is why in 2019, we launched a pilot program in France to transform our industrial activities. A great adventure for our teams, who are mobilising all their know-how to continue to develop the Virbac production sites in terms of performance, safety and quality. Watch the 2019 achievements in video.

Read more

2019 annual results

2020/03/16 - Financial public releases

2019 operating profit from ordinary activities on the rise

Read more

Pebble Labs and Virbac announce the signing of a comprehensive commercial agreement for aquaculture disease prevention

2020/03/11 - Press

Pebble Labs vignette.jpgFind out the press release dated March 9.

Read more


2020/02/26 - Products

Neonatal gastroenteritis is the leading cause of calf mortality before the age of one month and causes significant losses to farmers. With our Calf Care Solutions program, we work with veterinarians and farmers to adopt a comprehensive calf health management approach that integrates diagnosis, prevention and care. Our goal is to share our tools and technical knowledge to more effectively manage on-farm diarrhea episodes through sustainable farming practices that respect animal welfare.

Read more

Asia: better meeting tomorrow's food needs

2020/01/30 - Press

Vignette-300x200.jpgEnd of November, the Virbac teams shared for one day the groundbreaking ceremony of a new research & development center in Taiwan. This site will be dedicated to the support of aquaculture and swine farming activities in Asia.

Read more

Virbac opens a new path in the treatment of canine skin tumors

2020/01/20 - Products

STELFONTA.jpgThrough its partnership with QBiotics, Virbac is providing veterinarians in Europe with a breakthrough injectable solution to treat mastocytoma in dogs. With this new treatment, the Group once again demonstrates its commitment and ability to offer innovative solutions for the advancement of veterinary science.

Read more

2019 Annual consolidated sales

2020/01/16 - Financial public releases

2019 annual revenue shows strong growth of +6.6% at constant exchange rates

Read more

Happy new year!

2020/01/06 - Press

Sébastien Huron, chairman of the executive board of the Virbac group, wishes a happy new year for 2020 through a video.

Read more

The Group raises the 2019 annual outlook

2019/12/20 - Financial public releases

Read more

Mexico: Virbac supports young French companies

2019/12/05 - Press

Vignette-Partenariat-Mexique-300x200.jpgAs part of the French Fab mission lead by the French public investment bank (Bpifrance), Virbac sponsors a support mission in 2019 for young French companies wishing to establish themselves in Mexico.

Read more

An extra help for dogs’ relaxation and mobility

2019/11/26 - Products

Vignette_veggiedent.gifBehavior disorders and joint problems are common in dogs and can affect their quality of life and their relationship with humans. With multifunctional chews, pet owners now have an easy to give solution to support their pet’s overall health and wellness, while acting on their dental hygiene.

Read more

Dog obesity: a complete program offered by Virbac

2019/11/15 - Products

Today 25 to 40% of dogs are overweight or obese. This is true everywhere in the world, whatever the size or breed. Since obesity can have serious health consequences, Virbac offers, in partnership with an expert in dog activity, PitPat, a comprehensive program combining a healthy diet and the measurement of the dog's activity using a device placed on its collar. Find out more about this approach that helps improve the relationship between the owner and his pet by watching the video below.

Read more

Jean-Pierre Dick steps down from the executive board of the Virbac group

2019/11/05 - Press

Virbac has accepted Jean-Pierre Dick’s resignation from the executive board, effective November 14, 2019.

Read more

Micro-nutrition: a key role in feeding ruminants

2019/10/15 - Products

Today, farmers have to ensure optimal farming conditions both for the animal welfare and productivity. Yet, in the lifetime of an animal or during the production cycle, there are periods where induced oxidative stress is particularly intense. In such cases, farmers have to supplement animals with trace mineral elements. To learn more about micro-nutrition, click below to watch the video.

Read more

2019 third quarter consolidated sales

2019/10/11 - Financial public releases

Solid +8.4% growth in revenue at constant exchange rates at the end of September, 2019

Read more

Virbac Mexico celebrates 30 years

2019/10/11 - Press

30Vignette.jpgThis year marks the 30th year of Virbac’s iconic Latin American subsidiary, and they wished to celebrate the past thirty years of innovation and dedication to animal health along with their employees and customers on October 5, 2019. With a unique vision aligned to the Virbac Group’s values, the company has always taken its environmental impact and its social responsibility towards employees to heart.

Read more

Stock exchange: Virbac again in the SBF 120

2019/09/19 - Financial public releases

Following the quarterly review of its indices, the Paris stock exchange operator, Euronext, includes Virbac in the CAC Mid 60 and SBF 120 as from 23 September.

Read more

2019 half year results

2019/09/16 - Financial public releases

Operating profit on the rise in the first half of 2019

Read more

China: a new technology to support dental hygiene in dogs

2019/09/05 - Products

Lancement Chine vignette 300x200.jpgA major concern for pet owners, bad breath can disrupt the close bond between pet and owner and signal deeper health issues. In 2019, for the first time ever in China, Virbac introduced dental care solutions that include FR3SH™ technology to target the oral and digestive causes of bad breath.

Read more

Newcomers digital programme: a better way of sharing the corporate culture

2019/08/02 - Career

Digital Newcomers 300x200.jpgIn early June, Virbac launched a digital program dedicated to all new employees. Objective: within the first weeks of their arrival, build a common foundation of knowledge about the Group, its operations and its corporate culture.

Read more

Cyrille Petit appointed as a member of the Virbac supervisory board

2019/07/18 - Financial public releases

Cyrille Petit.jpgVirbac announces the arrival of Cyrille Petit as a member of the supervisory board as of June 18, 2019. In addition, on the audit committee he will replace Olivier Bohuon, who is also a member of the supervisory board.

Read more

2019 second quarter consolidated sales

2019/07/16 - Financial public releases

2019 first half-year revenue grew by +6.6% at constant exchange rates

Read more

Turkey: the first veterinary vaccine against canine leishmaniosis

2019/07/10 - Products

CaniLeish Turquie 300x200.jpgIn Turkey, the prevalence of canine leishmaniosis can reach 25% in some regions, especially around the Mediterranean basin. To face this zoonosis that is currently under-diagnosed by veterinarians and misunderstood among Turkish owners, Virbac has made available, since March 2019, CANILEISH®, the first veterinary vaccine to prevent this disease.

Read more

Sustainable development: an ever-greater commitment

2019/06/06 - Press

DPEF Vignette 300x200.jpgAs part of its 2018 annual report, Virbac published its first non-financial performance statement in April. This document marks a new stage for the Group, who is reinforcing its commitments to sustainable development.

Read more

Vietnam: a sustainable collaboration with farmers

2019/05/21 - Press

Husbandry Club Vignette 300 x 200.jpgEnd of 2018, the Virbac Husbandry Club in Vietnam, which helps pig and poultry farmers tackle local animal health issues, celebrated 10 years of activity. This 10th anniversary is a testament to the Group’s drive to carry out sustainable actions that promote improvement in farming conditions.

Read more

Disability: fostering job retention

2019/04/18 - Career

Handicap Vignette 300x200.jpgAs part of its diversity policy, Virbac has been conducting concrete actions for the recruitment, better integration and job retention of workers with disabilities since 2014 in France.

Read more

2019 first quarter consolidated sales

2019/04/11 - Financial public releases

2019 first quarter revenue rose by +10.9% at comparable exchange rates

Read more

United Kingdom: the Veterinary HPM™ campaign wins an award!

2019/04/05 - Products

Mid-March, Virbac was rewarded in the United Kingdom for its digital Veterinary HPM campaign by the VMA (Veterinary marketing association), which annually celebrates the best marketing initiatives in the field of animal health.

Read more

Innovation: the Smart Cap “all in one” is rewarded again!

2019/03/20 - Press

Each year, the ADF Paris awards honor the packaging innovations of the global aerosol and dispensing industries. Last January, the Virbac Smart Cap "all-in-one", already awarded in 2018 by Pharmapack, received the prize for the best innovation in the "Pharmacy" category.

Read more

2018 annual results

2019/03/18 - Financial public releases

2018 operating profit from ordinary activities grew by 13.4%

Read more

Dogs’ dental health: an online awareness campaign that really bites!

2019/01/31 - Products

At the end of 2018, Virbac launched an online campaign in North America encouraging owners to consult their veterinarian about their dog’s dental health. It included a humorous video broadcasted on social networks, featuring a rubber toy that hates being chewed by a dog with bad breath.

Read more

2018 Annual consolidated sales

2019/01/17 - Financial public releases

2018 annual revenue grew by +4.5% at constant exchange rates

Read more

Happy new year!

2019/01/10 - Press

Sébastien Huron, chairman of the executive board of the Virbac group, wishes all the best for 2019 through a video.

Read more

Virbac websites: make the access to information easier

2018/12/21 - Press

vignette.jpgIn 2018, several Virbac websites were revamped: new contents, new design, new functionalities… all these changes aim at creating a better user experience.

Read more

United States: in-house manufacturing of Virbac flagship parasiticide

2018/12/06 - Products

In August, the FDA approved the transfer of production to the Virbac St. Louis site (Missouri) of a parasiticide for dogs acquired by the company at the beginning of 2015. The complexity of the industrial extrusion process required all the skills and attention of the American subsidiary and the Group's Production/Quality teams for nearly three years.

Read more

A better dental care for an optimal dogs’ health

2018/11/22 - Products

VEGGIEDENT 200.jpgBad breath is a common complaint of dogs’ owners but it can also be a sign of periodontal or digestive issues that can be painful for the pet. Thanks to a new formula, the C.E.T® VEGGIEDENT® FR3SH dental chews tackle the oral causes of bad breath and help to restore the animal's intestinal balance while freshening its breath. Available since 2018 in the United States, Canada, the United Kingdom, France, Spain and Japan, they will gradually be present around the world in 2019.

Read more

Gaïa Index: Virbac ranked again in 2018!

2018/11/13 - Press

Virbac_Certificat_GaïaRating_2018_CA_Sup500.jpg (Présentation PowerPoint)In 2018, Virbac is part of the Gaïa Index, which recommends the 70 French companies with the best ratings in terms of social and environmental responsibility among a panel of 230 firms. Virbac has made a significant improvement of 14 places in the overall ranking compared to 2017.

Read more

Turkey: Virbac closer to the field

2018/10/23 - Press

Turquie_Vache.jpgAfter a twenty-year presence in Turkey through a local distributor, Virbac is creating its 33rd subsidiary there. The objective: closer proximity in order to better respond to the expectations of animal health players.

Read more

2018 third quarter consolidated sales

2018/10/11 - Financial public releases

Revenue grew by +5.5% at constant exchange rates at the end of September 2018

Read more

2018 half year results

2018/09/17 - Financial public releases

Operating profit up sharply in the first half of 2018

Read more

2018 second quarter consolidated sales

2018/07/17 - Financial public releases

Revenue grew by +4.3% at constant exchange rates in the second quarter of 2018

Read more

Virbac wins the Pharmapack Award with its “all-in-one” Smart Cap

2018/06/12 - Press

Pharmapack_599X400.jpgAfter five years of research and development, Virbac teams have developed Smart Cap, dedicated to extracting liquid products. This patented innovation benefitting animal health, which combines ergonomics and safety, was recognized in early 2018 with a Pharmapack Award.

Read more

Virbac United States announces Eric Bonner as vice president of Industrial Operations

2018/04/17 - Career

Eric Bonner-resize200x259.pngVirbac United States announced that Eric Bonner has been named vice president of Industrial Operations.

Read more

Supporting farmers to better manage swine reproduction

2018/04/12 - Products

Virbagest-resize200x133.JPGOne of the present challenges of swine producers is finding solutions that preserve farm productivity while reducing the use of antibiotics. In Europe, Latin America and Asia, Virbac is assisting veterinarians and farmers with technical solutions and on farm training that focus on prevention and are based on a good reproduction management.

Read more

2018 first quarter consolidated sales

2018/04/12 - Financial public releases

2018 first quarter revenue rose by +3.3% at comparable exchange rates

Read more

Webcast 2017 annual results

2018/03/19 - Financial public releases

Read more

2017 annual results

2018/03/14 - Financial public releases

Operating profit from ordinary activities 2017 comparable to 2016

Read more

Facilitate diagnosis to better care for the animal

2018/02/28 - Products

Speed-Reader-200X300.JPGSince 2017, Virbac has been offering veterinarians Speed ReaderTM, a blood marker dosage analyzer with a series of biomarker tests. Usable directly in-clinic, these newest additions to the diagnostic range facilitate screening of common diseases in cats and dogs and ensure better monitoring of the animal.

Read more

Healthy cows make better milk!

2018/01/17 - Products

Maintaining good health and welfare of cows is central to Virbac's approach of dairy production. Virbac created a specific program for professionals of dairy farming called Target 150. This program aims at bringing global & integrated solutions and protocols for a better and more sustainable production of milk. Developed in close cooperation with worldwide known experts, Target 150 ™ encourages prevention and answers the main problematics of the 150 critical days of production cycle of the dairy cows. As an essential part of the program, the second Virbac Dairy Symposium was organized in September 2017 to contribute strengthening the skills of dairy farming professionals and prepare them to the emerging technologies of tomorrow.

Read more

2017 Annual consolidated sales

2018/01/16 - Financial public releases

Annual sales comparable to 2016 at constant exchange rates after strong fourth-quarter growth

Read more

Happy new year!

2018/01/08 - Press

For 2018, find out the video wishes from Sébastien Huron, new chairman of the executive board of the Virbac group.

Read more

Sébastien Huron officially takes office as chairman of the Virbac group executive board

2017/12/21 - Career

Sébastien Huron.jpgYesterday, Virbac’s supervisory board officially appointed Sébastien Huron as chairman of the Group’s executive board. Sébastien Huron succeeds Éric Marée, chairman of the executive board for the past 18 years, who has retired. 

Read more

China: Virbac acclaimed by the largest pet owners community

2017/12/05 - Press

Goumin-_affiche_Chine.jpgIn August 2017, Virbac was awarded pet owner favorite brand for cat health care by, the largest online Chinese pet owner community. 

Read more

Aquaculture: Virbac postpones its option to buy Centrovet for three years

2017/11/22 - Financial public releases

By mutual agreement, Virbac and the other shareholders of Centrovet have decided to postpone the option to buy the Chilean aquaculture specialist for three years, under the same pricing conditions.

Read more

ADULT WITH SALMON NEUTERED & ENTIRE CAT received a rating of 17.5/20 from INC - 60 Millions de Consommateurs french magazine June 2017 issue

2017/11/21 - Products

product-cat-neutered-entire-adult.pngTwo years after its launch, with a rating of 17.5/20, the VETERINARY HPM® Adult with salmon neutered & entire cat is one of the ‘best choices’ amongst thirteen dry cat foods (kibbles) tested by the INC (Institut National de la Consommation [French National Institute for Consumer Affairs]). This rating makes up for several years of development.

Read more

New solutions to fight against leishmaniosis in Brazil

2017/11/17 - Products

leishmaniose.jpgThe treatment of dogs infected with leishmaniosis has been authorized in Brazil since 2016. Thanks to its publicity campaigns and its treatment solution introduced in January 2017, Virbac is contributing to the fight against this disease which, on a world scale, touches about 1 million of humans. 

Read more

2017 third quarter consolidated sales

2017/10/12 - Financial public releases

Virbac: quarterly sales affected by distributor destocking in the United States

Read more

VETERINARY HPM dietetic: a new generation of nutrition for cats and dogs

2017/10/06 - Products

VETERINARY HPM™ dietetic is a new generation of nutrition for cats and dogs with health problems, created by staying close to the nutritional requirements of carnivores, respecting the nutritional requirements of carnivores. These foods should be recommended by the veterinarian depending on the animal's health problem. A veterinarian's option should be sought before use. Available since spring 2017 in European veterinary clinics, the VETERINARY HPM™ dietetic range will also be launched in Latin America (Mexico, Costa Rica and Chile) by the end of the year.

Read more

Virbac group: Solène Madelpuech joins the supervisory board

2017/09/22 - Financial public releases

Madelpuech_Solene.jpgOn September 5, 2017, Virbac’s supervisory board co-opted Solène Madelpuech into the supervisory board as a new member. On the same day, Jeanine Dick, aged 81, announced her resignation. 

Read more

Virbac appoints Sophie Favini as executive vice-president of US commercial operations

2017/09/14 - Career

Sophie-Favini-1.jpgVirbac announces the appointment of Sophie Favini as executive vice-president of US commercial operations. Based in Fort-Worth (Texas), she is effective in her role since July 13, 2017. Sophie Favini is now in charge of leading, developing and overseeing all US Sales, Marketing and Technical Services functions in order to increase the business activity of the subsidiary.
Virbac also announces the appointment of Colin Meyers as vice-president of sales. These two appointments will help Virbac achieve a sustainable growth in the US. 

Read more

2017 half year results

2017/09/11 - Financial public releases

Slight increase in first half results

Read more

Calf Health: Virbac boosts its expertise

2017/08/10 - Products

vaches-veau.jpgWhether in the meat or dairy industries, quality production requires animals that are healthy from birth onward! With this in mind, Virbac has been progressively rolling out a complete Calf health management program in Europe since 2016. 

Read more

2017 second quarter consolidated sales

2017/07/17 - Financial public releases

Virbac: second quarter sales growth largely offsets the decline in the first quarter

Read more

Virbac group: Sébastien Huron will become the new chairman of the executive board as of December 2017

2017/06/23 - Career

Virbac has announced the supervisory board’s intention to appoint Sébastien Huron as chairman of Virbac’s executive board, as of next December, when the mandate of the current chairman of the executive board, Éric Marée, expires. 

Read more

Virbac signs a research agreement with Bio-Gene

2017/06/16 - Press

Bovin_photo.jpgBio-Gene announces collaboration agreement with Virbac for development of FLAVOCIDE™ as an insect control agent in ruminants. 

Read more

Effipro® Duo: treat and prevent flea and tick infestations

2017/05/31 - Products

In May 2016, European practitioners (France, UK and Austria) discovered Effipro® Duo, a new parasiticide used to treat and prevent tick and flea infestations in dogs and cats. The advantages of this product described by the Global Marketing manager parasiticides.

Read more

Launch of the VETERINARY HPM™ Dietetic range in Europe!

2017/05/10 - Products

couverture_HPM-1.jpgFollowing the launch of the VETERINARY HPM™ physiological range in 2015, Virbac started from March 1st the launch of VETERINARY HPM™ dietetic for dogs and cats in Europe. A complete range still close to the nutritional requirements of carnivores and associated to the "Veterinary global care", a new global nutritional approach.

Read more

Virbac United States selects KC Animal Health Corridor for North American distribution center

2017/05/04 - Press

The Virbac American subsidiary decided to gather its distribution operations in Hunt Midwest SubTropolis (Missouri). The new center should be operational until the end of the year.

Read more

2017 first quarter consolidated sales

2017/04/12 - Financial public releases

First quarter 2017 sales down, strongly impacted by stock effects in the distribution in the United States

Read more

VETERINARY HPM® Adult Small & Toy: a rating of 16.4/20

2017/04/04 - Products

product-dog-smallandtoy-adult.pngThe product VETERINARY HPM® Adult Small & Toy has received a rating of 16.4/20 from the independent French consumer association UFC-Que Choisir. The cited product has been qualified as one of the “best choices” amongst the twenty complete dog foods that were tested. 

Read more

Supporting innovation through public research

2017/03/31 - Press

Public_research.jpgPublic-private transfer (TPP). Behind this acronym lies the possibility for French companies to develop partnerships with French and European public research organizations. This opportunity for innovation was seized on by Virbac in 2009 and presented by the public research partnerships manager. 

Read more

2016 annual results

2017/03/13 - Financial public releases

Strong rebound in profitability in 2016  

Read more

e-visit: always closer to veterinarians

2017/02/27 - Press

Ee-visite.jpgIn September 2016, on the initiative of the IT department, e-visits first appeared amongst the sales force in France. The purpose: allow greater reactivity from regional technical managers to questions from veterinarians. Explanations on this European-scale project by the market manager for Virbac France.

Read more

Argo Navis: now 100% operational

2017/02/14 - Press

ArgoNavis_Ext.jpgAt the end of September, 2016, all activity at the Mayas factory in Mexico was transferred to the new industrial site of Argo Navis. A look back on this major project and the challenges it presented with the Virbac Mexico Industrial director.

Read more

2016 Annual consolidated sales

2017/01/17 - Financial public releases

Annual sales growth of 4.5%, at constant exchange rates

Read more

St. Louis: lifting of the Warning Letter for the Virbac production site

2016/12/16 - Financial public releases

Virbac announces that it has received from the Food and drug administration (FDA) a communication confirming the lifting of the Warning Letter received in December 2015 for its St. Louis production site (Missouri, USA).

Read more

Argo Navis becomes Virbac’s new production site in Mexico

2016/11/23 - Press

ArgoNavis.jpgXavier Montat, general manager of Virbac Mexico since last year, announces the transfer of all production operations to the Argo Navis site in Guadalajara. This relocation marks the completion of the project launched in 2011 to support the strong growth of the Virbac Mexican subsidiary.

Read more

2016 third quarter consolidated sales

2016/10/13 - Financial public releases

Sales grow by 3.2% at the end of September at constant rates

Read more

"Factories and Men" Exhibition: Virbac at the forefront!

2016/10/08 - Press

Affiche Virbac JCDecaux_134.jpg14 September 2015, Paris. The "Factories and Men" operation is being organised by 'Mouvement des entreprises de taille intermédiaire' (METI), an organisation which represents intermediate-sized businesses in France. The project began with a preview at the Petit Palais, and METI has organised a series of events which will take place until the end of 2015 with the aim of spotlighting the best of French industry. Thirty five businesses, including Virbac, are taking part. 

Read more

Virbac China, still one step ahead

2016/09/29 - Products

CHIEN.jpgSince 2012, Virbac has maintained a presence in China through a commercial subsidiary that now has about thirty collaborators. How is the subsidiary adapting to this ever-changing market? Answers by the subsidiary general manager.

Read more

2016 half year results

2016/09/19 - Financial public releases

Growth of half-year results

Read more

USA: Virbac launches of unique canine joint health supplement

2016/09/19 - Products

MOVOFLEX-soft-chews.pngOn March 8, 2016, Virbac US announced the launch of the latest advancement in canine joint health supplementation, MOVOFLEX™ Soft Chews. Formulated with a unique and proprietary blend of ingredients, MOVOFLEX™ Soft Chews provide comprehensive canine joint support in a once-a-day palatable soft chew.

Read more

Marie-Paule Porte appointed Group general counsel at Virbac

2016/08/30 - Career

Marie-Paule_Porte.jpgVirbac announces the appointment of Marie-Paule Porte as Group general counsel. Member of the strategic committee and the Comex France, in charge of legal matters at a global level, she provides support to the executive board and area directors in relation to strategic decisions they take.

Read more

Sustainable development: a new step

2016/07/28 - Press

Dev-Mag.pngIn its 2015 report, Virbac adopted the most recent version of the GRI standard for sustainable development. The reasons behind this change and the related benefits explained by Éric Marée, chairman of the executive board.

Read more

2016 second quarter consolidated sales

2016/07/18 - Financial public releases

Sales growth by 3.6% at constant exchange rates in the first half

Read more

Habib Ramdani appointed chief financial officer at Virbac and member of the executive board

2016/06/29 - Career

Ramdani_Habib.jpgVirbac announces the appointment of Habib Ramdani as chief financial officer. Appointed to the executive board on June 23, 2016, Habib has overseen all financial activities of the Group since taking office on May 2, 2016, reporting directly to Éric Marée, chairman of the Virbac group executive board.

Read more

Andres Engelbreit appointed Latin American area director for Virbac

2016/05/09 - Career


Virbac announces the appointment of Andres Engelbreit as Latin American area director as of January 1, 2016. In conjunction with the business development, innovation and global marketing teams, Andres Engelbreit’s missions are to increase the Virbac’s market share in Latin America and improve its profitability in the area in a lasting way. He has been a development director in the area since 2012.


Read more

USA: Virbac launches a new dental Diagnostic Test

2016/05/02 - Products

OraStrip-CET.pngOn March 1, 2016, Virbac US announced the launch of the C.E.T.® OraStrip® Dental Diagnostic Test (currently distributed in the USA), the first and only test in the animal health market that detects periodontal infection in dogs, providing visual test results to support veterinarians’ dental treatment recommendations and enhance client compliance.

Read more


2016/04/22 - Products

Virbac has been distributing the parasiticide medicines Activyl® and Activyl® Tick Plus in Europe since January 1, 2016. The integration of these two medicines in the parasiticide product portfolio fulfils Virbac’s wish to offer complementary solutions to veterinarians.

Read more

2016 first quarter consolidated sales

2016/04/13 - Financial public releases

Sales in the first quarter 2016 : return to organic growth

Read more

USA: Virbac creates 144 jobs in Bridgeton, Missouri

2016/04/13 - Press

Virbac is investing $37.9 millions in its production site in Bridgeton, Missouri.

Read more

Instrucciones: a new high quality facility

2016/03/17 - Press

Instrucciones Bat.jpg (TRIPTICO PLANTA Instrucciones web)A 3,600 m² space dedicated to production! At the end of September the new Instrucciones site was opened in Uruguay, with a special emphasis on quality. An introduction to this leading edge facility by the subsidiary’s general manager.

Read more

2015 annual results

2016/03/14 - Financial public releases

2015 annual results heavily impacted by the United States

Read more

New tagline: Virbac shows its ambition!

2016/03/12 - Press

web_sign.jpgShaping the future of animal health”. This is now Virbac's new tagline, replacing “Passionate about animal health”, launched in 2001.
What message does this new slogan convey? Answers from Sandrine Brunel, head of Corporate Communications.

Read more

VETERINARY HPM: Virbac’s new generation Pet food!

2016/03/01 - Products

HPM-CHAT-300X200.jpgVirbac commercializes a new hyper premium nutritional concept for dogs and cats! 

Over the last months, Virbac has progressively launched its new range Veterinary HPM™ for cats and dogs in more than ten European countries (Denmark, Switzerland, France, Portugal, Spain…).

Read more

VDS: Virbac's commitment to the dairy sector

2016/02/20 - Press

VDSAt the beginning of October the GMBO (Global Marketing) organized the first Virbac Dairy Symposium in France, attended by experts from the dairy sector and Virbac staff from all over the world. Fabrice Payot, Global Marketing manager on the dairy cattle segment, explains the objectives of this major event. 

Read more

Colombia: vaccines for companion animals, a dominant position

2016/02/03 - Products

VaccinColombie.jpg26%. This is 2014 Virbac Colombia's market share on the dog and cat vaccines segment. This figure is evidence of the success that the subsidiary has met with in this fast-growing sector. The story of a lightningfast journey by colombian Marketing manager.

Read more

Changing views on disability

2016/01/20 - Career

picto-handicap.jpgAs well as gender equality, age equality, now it's the turn of disability.
As part of its diversity policy in France, at the end of 2014 Virbac signed an agreement with its social partners on this important theme within the company. Details of the content of this agreement with the diversity manager for France.

Read more

2015 Annual consolidated sales

2016/01/14 - Financial public releases

Annual sales growth of 10.2%, driven by exchange rates and acquisitions

Read more

New Zealand: Thrilling challenges ahead

2015/12/11 - Products

VirbacNZ.jpgNew premises, dairy crisis, market concentration... 2015 is marking a turning point for the subsidiary in New Zealand. How are such evolutions to be tackled? Answers from general manager of the subsidiary.

Read more

Jules Minke joins Virbac as biological R&D director for the Group

2015/11/06 - Career


Virbac announces the appointment of Jules Minke as Group biological Research and Development director. Jules Minke’s main task going forward is to coordinate and supervise all R&D activities and global teams involved in Virbac’s biological projects. He will also monitor regulatory activities in this area.

Read more